What metabolic and hemodynamic parameters were affected most significantly in LEADER and what new information did we learn about the safety profile of liraglutide?

What metabolic and hemodynamic parameters were affected most significantly in LEADER and what new information did we learn about the safety profile of liraglutide?

What metabolic and hemodynamic parameters were affected most significantly in LEADER and what new information did we learn about the safety profile of liraglutide?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Lawrence Leiter, MD, FRCP(C), FACP

Lawrence Leiter, MD, FRCP(C), FACP

Head, Division of Endocrinology and Metabolism Director, Lipid Clinic Associate Director, Clinical Nutrition and Risk Factor Modification Centre St. Michael’s Hospital Professor of Medicine and Nutritional Sciences University of Toronto Toronto, Ontario